# AI-Powered Osteoarthritis Prediction Platform
## Technical Overview for Precision Diagnostics Applications

---

## Project Overview

The Digital Osteoarthritis Counseling (DOC) platform is an AI-powered prediction system that identifies patients at high risk for total knee replacement (TKR) surgery and predicts post-surgical patient satisfaction outcomes. Developed in collaboration with the Netherlands Olympic Committee (NOC*NSF) and Bergman Clinics, the platform combines machine learning models with automated literature mining to provide evidence-based, clinically validated predictions that integrate seamlessly into orthopedic care workflows.

---

## Technical Approach

### Model Architecture

The platform employs a two-stage prediction system built on ensemble machine learning algorithms:

- **Stage 1 - Surgery Prediction Model:** Random Forest classifier predicting 4-year TKR necessity (AUC = 0.862)
- **Stage 2 - Outcome Prediction Model:** Random Forest regressor predicting post-surgical WOMAC improvement and patient satisfaction

Both models were developed using rigorous methodology aligned with PROBAST (Prediction model Risk Of Bias ASsessment Tool) standards, achieving **LOW RISK OF BIAS** across all four assessment domains—placing the system in the **top 7%** of published osteoarthritis prediction models.

### Key Features and Inputs

The models utilize 10 baseline clinical variables that are routinely collected in standard orthopedic practice:

- **Imaging:** Bilateral knee X-ray KL (Kellgren-Lawrence) grades (structural severity)
- **Patient-Reported Outcomes:** WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) scores for pain, stiffness, and function
- **Demographics:** Age, sex, BMI
- **Clinical History:** Family history of osteoarthritis

All predictors are measured at baseline, ensuring the models can be applied at the point of initial patient evaluation without requiring follow-up data.

### Performance Metrics

**Surgery Prediction Model:**
- **Discrimination:** AUC = 0.862 (excellent)
- **Calibration:** Brier Score = 0.0307 (after Platt scaling)
- **Sample Size:** 4,796 patients from Osteoarthritis Initiative (OAI) dataset
- **Events per Variable (EPV):** 17.10 (exceeds minimum threshold of 15)

**Outcome Prediction Model:**
- **Prediction Accuracy:** RMSE = 14.63 WOMAC points, R² = 0.407
- **Sample Size:** 381 surgery patients with post-operative outcomes
- **Clinical Utility:** Predicts expected improvement in patient-reported outcomes

---

## Clinical Validation Process

### Collaborative Development Framework

The platform was developed through close collaboration with clinical partners, ensuring real-world applicability:

- **Clinical Lead:** Dr. Maarten Moen, Chief Medical Officer, NOC*NSF / Bergman Clinics
- **Validation Site:** Bergman Clinics (Netherlands), a leading orthopedic practice network
- **Development Partner:** StroomAI (technical implementation)

### Current Validation Status

**Active Clinical Testing:**
- Prospective external validation study protocol designed and ready for implementation
- Target: 500 patients at Bergman Clinics over 5.5 years (12 months enrollment + 48 months follow-up)
- Real-world testing approach: Model predictions integrated into clinical workflow for evaluation alongside standard care

**Validation Methodology:**
- Geographic validation: US-based training data (OAI) → European population (Netherlands)
- Temporal validation: Model trained on 2004-2014 data, validated in 2025+
- Healthcare system validation: Different payment and care delivery models

This collaborative validation process ensures the models are not just theoretically sound but practically applicable in real clinical settings, with ongoing feedback from practicing orthopedic surgeons.

---

## Key Innovations

### 1. Automated Literature Mining for Continuous Improvement

The platform includes a built-in PubMed literature monitoring system that:

- **Automated Discovery:** Daily searches of PubMed for relevant osteoarthritis research
- **Intelligent Filtering:** Two-stage filtering system (keyword matching → AI relevance scoring) that reduces processing costs by 83% while maintaining quality
- **Model Updates:** Automatically flags research that may impact model predictions, triggering targeted recalculation when new evidence emerges
- **Evidence Integration:** Extracts predictive factors, treatment outcomes, and biomarker associations from published literature

This continuous learning capability ensures the platform remains current with evolving medical evidence without requiring manual literature review.

### 2. Clinical Workflow Integration

The platform was designed with clinical workflow constraints in mind:

- **WOMAC Score Discussion:** Models incorporate patient-reported WOMAC scores, which are already part of standard orthopedic consultations, requiring no additional data collection burden
- **Point-of-Care Application:** All inputs are available at baseline evaluation, enabling immediate risk assessment
- **Interpretable Outputs:** Risk stratification into four clinically meaningful groups (low, moderate, high, very high risk) with clear probability estimates
- **Dual Prediction:** Addresses both surgical necessity (when will surgery be needed?) and surgical success (how much will the patient benefit?), supporting shared decision-making

### 3. Dual Prediction Targets

Unlike most prediction models that focus solely on disease progression, the DOC platform predicts both:

- **TKR Necessity:** Probability of requiring total knee replacement within 4 years
- **Patient Satisfaction:** Expected post-surgical WOMAC improvement, enabling surgeons to identify patients likely to experience meaningful benefit from surgery

This dual approach supports more nuanced clinical decision-making, helping identify patients who both need surgery and are likely to benefit from it.

---

## Transferable Capabilities for Other Healthcare ML Projects

The methodologies, infrastructure, and validation processes developed for the DOC platform are directly applicable to other precision diagnostics applications, including diabetes prediction:

### 1. Rigorous Model Development Framework

- **PROBAST-Compliant Methodology:** Systematic approach to bias prevention that ensures publication-ready models
- **Adequate Sample Size Planning:** EPV calculations and power analysis for robust model development
- **Proper Missing Data Handling:** Multiple imputation (MICE) rather than case deletion
- **Overfitting Prevention:** Cross-validation, hyperparameter tuning, and independent test sets

### 2. Clinical Integration Expertise

- **Workflow-Aware Design:** Understanding of what data is routinely collected vs. what requires additional effort
- **Clinician Collaboration:** Experience working directly with medical professionals to ensure practical utility
- **Interpretability Focus:** Models designed to produce outputs that clinicians can understand and trust

### 3. Continuous Learning Infrastructure

- **Automated Literature Mining:** PubMed monitoring system can be adapted to any medical domain
- **Evidence Integration Pipeline:** Framework for incorporating new research into existing models
- **Cost-Effective AI Processing:** Two-stage filtering system reduces computational costs while maintaining quality

### 4. Validation and Regulatory Readiness

- **External Validation Protocol Design:** Experience creating prospective validation studies
- **Regulatory Pathway Understanding:** Knowledge of EU MDR and FDA requirements for diagnostic software
- **Real-World Testing Approach:** Methodology for validating models in actual clinical settings

### 5. Two-Stage Prediction Architecture

The dual-model approach (necessity + outcome) can be adapted to other conditions:
- **Diabetes:** Predict disease progression AND treatment response
- **Cardiovascular:** Predict event risk AND medication effectiveness
- **Oncology:** Predict cancer risk AND treatment success probability

---

## Conclusion

The DOC platform demonstrates a comprehensive approach to developing clinically useful AI prediction tools: rigorous methodology, active clinical collaboration, real-world validation, and continuous improvement through automated evidence integration. These capabilities—particularly the focus on clinical workflow integration, dual prediction targets, and automated literature mining—represent transferable expertise directly applicable to precision diagnostics projects in diabetes and other chronic conditions.

---

**Contact:** parker@stroomai.com  
**Development Partner:** StroomAI  
**Clinical Partner:** NOC*NSF / Bergman Clinics (Dr. Maarten Moen, CMO)

